These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 20734280)

  • 1. Bilateral total knee arthroplasty in a patient with hemophilia A, high inhibitor titre and aneurysma spurium of the popliteal artery. A case report.
    Frauchiger LH; Harstall R; Kajahn J; Anderson S; Eggli S
    Swiss Med Wkly; 2010; 140():w13094. PubMed ID: 20734280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Major surgery in a severe haemophilia A patient with high titre inhibitor: use of the thrombin generation test in the therapeutic decision.
    Dargaud Y; Lienhart A; Meunier S; Hequet O; Chavanne H; Chamouard V; Marin S; Negrier C
    Haemophilia; 2005 Sep; 11(5):552-8. PubMed ID: 16128902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factor (F)VIII/VIIa enhances global haemostatic function in the co-presence of bypassing agents and FVIII among patients with haemophilia A with inhibitor.
    Nogami K; Matsumoto T; Yada K; Ogiwara K; Furukawa S; Shida Y; Takeyama M; Shima M
    Br J Haematol; 2018 May; 181(4):528-536. PubMed ID: 29611182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined administration of FVIII and rFVIIa improves haemostasis in haemophilia A patients with high-responding inhibitors--a thrombin generation-guided pilot study.
    Livnat T; Martinowitz U; Azar-Avivi S; Zivelin A; Brutman-Barazani T; Lubetsky A; Kenet G
    Haemophilia; 2013 Sep; 19(5):782-9. PubMed ID: 23659442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of haemophilic arthropathy during childhood. May common orthopaedic management be extrapolated from patients without inhibitors to patients with inhibitors?
    Rodriguez-Merchan EC; Hedner U; Heijnen L; Jimenez-Yuste V; Lee CA; Morfini M; Querol F; Roosendaal G; Santagostino E; Solimeno LP
    Haemophilia; 2008 Nov; 14 Suppl 6():68-81. PubMed ID: 19134036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Perioperative use of recombinant activated factor VII (rF VIIa) in a patient with hemophilia A having inhibitors].
    Kawasaki Y; Saeki N; Kawamoto M; Yuge O; Fujii T
    Masui; 2005 Aug; 54(8):926-8. PubMed ID: 16104555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Orthopaedic surgery in haemophilia patients with inhibitors as the last resort.
    Rodriguez-Merchan EC; Quintana M; Jimenez-Yuste V
    Haemophilia; 2008 Nov; 14 Suppl 6():56-67. PubMed ID: 19134035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Approaches to successful total knee arthroplasty in haemophilia A patients with inhibitors.
    Konkle BA; Nelson C; Forsyth A; Hume E
    Haemophilia; 2002 Sep; 8(5):706-10. PubMed ID: 12199684
    [No Abstract]   [Full Text] [Related]  

  • 9. Economic evaluation of major knee surgery with recombinant activated factor VII in hemophilia patients with high titer inhibitors and advanced knee arthropathy: exploratory results via literature-based modeling.
    Ballal RD; Botteman MF; Foley I; Stephens JM; Wilke CT; Joshi AV
    Curr Med Res Opin; 2008 Mar; 24(3):753-68. PubMed ID: 18234151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knee joint arthroplasty in a patient with haemophilia A and high inhibitor titre using recombinant factor VIIa (NovoSeven): a new case report and review of the literature.
    Faradji A; Bonnomet F; Lecocq J; Grunebaum L; Desprez D; Kern O; Barbier L; Sibilia J
    Haemophilia; 2001 May; 7(3):321-6. PubMed ID: 11380637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uncomplicated neurosurgical resection of a malignant glioneuronal tumour under haemostatic cover of rFVIIa in a severe haemophilia patient with a high-titre inhibitor: a case report and literature review of rFVIIa use in major surgeries.
    Aouba A; Dezamis E; Sermet A; Rothschild C; Hermine O; Lasne D; Torchet MF
    Haemophilia; 2010 Jan; 16(1):54-60. PubMed ID: 19709314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of FVIII and by-passing agent potentiates in vitro thrombin production in haemophilia A inhibitor plasma.
    Klintman J; Astermark J; Berntorp E
    Br J Haematol; 2010 Nov; 151(4):381-6. PubMed ID: 20977448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-course use of recombinant factor VIIa in a haemophilia patient with inhibitor undergoing cataract surgeries.
    Pekçelen Y; Yavuz AS; Namli S; Gücükoglu A
    Blood Coagul Fibrinolysis; 2005 Sep; 16(6):445-6. PubMed ID: 16093736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylaxis in haemophilia with inhibitors: update from international experience.
    Carcao M; Lambert T
    Haemophilia; 2010 Mar; 16 Suppl 2():16-23. PubMed ID: 20132334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Periarticular aneurysm following total knee replacement in hemophilic arthropathy. A case report.
    Mann HA; Goddard NJ; Lee CA; Brown SA
    J Bone Joint Surg Am; 2003 Dec; 85(12):2437-40. PubMed ID: 14668517
    [No Abstract]   [Full Text] [Related]  

  • 16. Successful use of recombinant factor VIIa for hemostasis during total knee replacement in a severe hemophiliac with high-titer factor VIII inhibitor.
    Carr ME; Loughran TP; Cardea JA; Smith WK; Kuhn JG; Dottore MV
    Int J Hematol; 2002 Jan; 75(1):95-9. PubMed ID: 11843300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgery--a challenge in haemophiliacs with inhibitors.
    Serban M; Poenaru D; Pop L; Ionita H; Mihailov MD; Tepeneu N; Bădeţi R; Lighezan D; Schramm W
    Hamostaseologie; 2009 Oct; 29 Suppl 1():S39-41. PubMed ID: 19763345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost effectiveness of prophylactic treatment with activated prothrombin complex concentrate in a patient with inhibitor-positive hemophilia A.
    Nakamura S; Morimoto A; Oh Y; Hayase T; Kashii Y; Gunji Y; Momoi MY
    Blood Coagul Fibrinolysis; 2012 Apr; 23(3):235-7. PubMed ID: 22322137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost minimization analysis to compare activated prothrombin complex concentrate (APCC) and recombinant factor VIIa for haemophilia patients with inhibitors undergoing major orthopaedic surgeries.
    Bonnet PO; Yoon BS; Wong WY; Boswell K; Ewenstein BM
    Haemophilia; 2009 Sep; 15(5):1083-9. PubMed ID: 19456876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility of using thrombin generation assay (TGA) for monitoring bypassing agent therapy in patients with hemophilia having inhibitors.
    Ay Y; Balkan C; Karapinar DY; Akin M; Bilenoglu B; Kavakli K
    Clin Appl Thromb Hemost; 2013; 19(4):389-94. PubMed ID: 22395575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.